DekaBank Deutsche Girozentrale - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$241
+47.0%
100,0000.0%0.00%
Q2 2023$164
-33.1%
100,000
+25.0%
0.00%
-100.0%
Q1 2023$245
-40.5%
80,0000.0%0.00%0.0%
Q4 2022$412
-99.8%
80,0000.0%0.00%0.0%
Q3 2022$255,000
+65.6%
80,000
+263.6%
0.00%
Q3 2021$154,000
-27.7%
22,0000.0%0.00%
-100.0%
Q2 2021$213,000
+10.4%
22,0000.0%0.00%0.0%
Q1 2021$193,000
-22.5%
22,0000.0%0.00%0.0%
Q4 2020$249,00022,0000.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders